Exploring Cannabinoid Clinical Benefits for Autism in Children
This article reviews cannabinoid clinical benefits observed in a randomized trial of CBD for children with autism. The study highlights improvements in social relating, anxiety, and parental stress. These findings contribute to the growing clinical…
Cannabinoids for Autism: Clinical Research Systematic Review
Therapeutic use cannabis derivatives autism has been studied in clinical trials showing reductions in behavioral symptoms in children with autism. Cannabidiol-rich preparations demonstrated improvements in social responsiveness and quality of life.…
Endocannabinoid System Research: Cannabis & Child Development
Peripregnancy cannabis exposure is linked to behavioral and developmental differences in children, with varying effects based on autism spectrum disorder symptoms. This research highlights the importance of understanding maternal cannabis use during…
Cannabinoids for Autism: Clinical Evidence-Based Review
Cannabinoid clinical trials autism research shows promising signals for reducing irritability and hyperactivity in autism spectrum disorder. Evidence is limited by small sample sizes and trial variability. Larger, well-controlled studies are needed for…
Cannabinoid-based Interventions for Behavioral Outcomes in Children and Adolescents with Autism Spectrum Disorder
Cannabinoid interventions autism spectrum disorder show promise for improving behavioral outcomes in children and adolescents. This systematic review highlights safety and effectiveness data. Families and clinicians should consider these findings…
Can medicinal cannabis help kids’ autism, ADHD or Tourette’s? Here’s what we know so far
Pediatric cannabis use autism research is emerging but remains limited and observational. Safety concerns for ADHD and Tourette's in kids require careful clinical consideration. Families and clinicians must weigh benefits against risks with limited data.
Maternal Cannabis & Autism/ADHD Risk: Clinical Evidence
Maternal cannabis use in pregnancy risks research indicates a modestly elevated risk for autism spectrum disorder and ADHD in children. Cannabis compounds cross the placental barrier and may affect fetal brain development. These findings support caution…
Pilot Study Finds Salivary Metabolite Shifts in Autistic Children Treated with Medical Cannabis—But Evidence Remains Preliminary
This pilot study explores salivary metabolomics autism cannabis shifts in children with ASD after treatment. It identifies 65 candidate biomarkers but remains preliminary due to study limitations. Larger controlled trials are needed to confirm these…
Rigorous CBD Trial for Autism Behavioral Symptoms Launches—But Results Are Not Yet In
The CASCADE CBD autism trial protocol 2024 outlines a rigorous placebo-controlled crossover study of pharmaceutical cannabidiol for irritability and aggression in children with autism spectrum disorder. This trial addresses critical gaps by using…
Cannabinoids Show Modest, Low-Certainty Benefits for a Few Mental Health Conditions—But Widespread Clinical Use Is Not Justified
This 2026 review examines cannabinoids mental health benefits, revealing modest effects for select conditions. Evidence remains limited and of low certainty. Routine clinical use is not justified without further trials.
